Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Sever

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Journal of Cardiovascular Pharmacology|May 1, 1981
Renal function, body fluid volumes, renin, aldosterone, and noradrenaline during treatment of hypertension with pindololC S Wilcox, P S Lewis, W S Peart, et al.
American Heart Journal|March 31, 1999
QT dispersion in athletic left ventricular hypertrophyJ Mayet, P Kanagaratnam, M Shahi, et al.
American Journal of Hypertension|June 1, 1997
The effects on cardiac arrhythmias of antihypertensive therapy causing regression of left ventricular hypertrophyJ Mayet, N Chapman, M Shahi, et al.
Cardiovascular Research|July 1, 1995
The effects of antihypertensive therapy on carotid vascular structure in manJ Mayet, A V Stanton, A M Sinclair, et al.
Journal of Hypertension|June 14, 2001
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigatorsP S Sever, B Dahlöf, N R Poulter, et al.
Journal of Human Hypertension|November 1, 2001
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocolP S Sever, B Dahlöf, N R Poulter, et al.
Open Heart|February 4, 2025
Tissue Doppler echocardiography predicts long-term cardiovascular mortality: the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) legacy 20-year follow-up studyAnenta Ratneswaren, Tong Wu, Amit Kaura, et al.
Journal of Human Hypertension|November 19, 1997
Left ventricular hypertrophy, blood pressure and ACE genotype in untreated hypertensionJ Mayet, K P O'Kane, R Elton, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Journal of Cardiovascular Pharmacology|May 1, 1981
Renal function, body fluid volumes, renin, aldosterone, and noradrenaline during treatment of hypertension with pindololC S Wilcox, P S Lewis, W S Peart, et al.
American Heart Journal|March 31, 1999
QT dispersion in athletic left ventricular hypertrophyJ Mayet, P Kanagaratnam, M Shahi, et al.
American Journal of Hypertension|June 1, 1997
The effects on cardiac arrhythmias of antihypertensive therapy causing regression of left ventricular hypertrophyJ Mayet, N Chapman, M Shahi, et al.
Cardiovascular Research|July 1, 1995
The effects of antihypertensive therapy on carotid vascular structure in manJ Mayet, A V Stanton, A M Sinclair, et al.
Journal of Hypertension|June 14, 2001
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigatorsP S Sever, B Dahlöf, N R Poulter, et al.
Journal of Human Hypertension|November 1, 2001
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocolP S Sever, B Dahlöf, N R Poulter, et al.
Open Heart|February 4, 2025
Tissue Doppler echocardiography predicts long-term cardiovascular mortality: the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) legacy 20-year follow-up studyAnenta Ratneswaren, Tong Wu, Amit Kaura, et al.
Journal of Human Hypertension|November 19, 1997
Left ventricular hypertrophy, blood pressure and ACE genotype in untreated hypertensionJ Mayet, K P O'Kane, R Elton, et al.
Pageof 19